MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares
$16,38
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 10, 2026
52W-Spanne
$6–$63
18% of range
Analystenbewertung
BUY
22 analysts
Kursziel
$29
+74% upside
P/E (TTM)
-3.7
ROE
-60.5%
Nettogewinnmarge
—
MLTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$16.38
Marktkapitalisierung
—
P/E (TTM)
-3.7
EPS (TTM)
$-3.53
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-60.5%
Verschuldungsgrad
—
52W-Spanne
$6 – $63
MLTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-3.53
2022-12-31
→
2025-12-31
Freier Cashflow
$-196M
2022-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
MLTX
Peer-Median
P/E (TTM)
-3.7
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
MLTX
Peer-Median
ROA
-50.4%
-47.5%
ROE
-60.5%
-112.5%
ROIC
-80.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
MLTX
Peer-Median
Current Ratio (Liquiditätsgrad)
9.3
3.4
Quick Ratio
7.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
MLTX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
MLTX
Peer-Median
MLTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
22 Analysten
- Starker Kauf 7 31,8%
- Kauf 10 45,5%
- Halten 3 13,6%
- Verkauf 1 4,5%
- Starker Verkauf 1 4,5%
12-Monats-Kursziel
13 Analysten · 2026-08-16
Median
$30.00
Jetzt
$16.38
Tief
$6.00
Hoch
$50.00
Median-Ziel
$30.00
+83,2%
Mittelwert-Ziel
$28.54
+74,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.04%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.98 | $-0.91 | -0.07% |
| 31. Dezember 2025 | $-0.92 | $-1.01 | 0.09% |
| 30. September 2025 | $-1.10 | $-0.90 | -0.20% |
| 30. Juni 2025 | $-0.87 | $-0.74 | -0.13% |
| 31. März 2025 | $-0.63 | $-0.77 | 0.14% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MLTX | — | -3.7 | — | — | -60.5% | — |
| CRSP | $5.03B | -8.1 | -90.6% | -16569.8% | -32.0% | — |
| ACIU | — | — | — | — | — | — |
| ADCT | $444M | -3.2 | 14.8% | -175.3% | 74.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $203M | $113M | $32M | $42M | · | |
| SG&A Expense | $42M | $30M | $22M | $23M | $5M | |
| Operating Expenses | $245M | $143M | $54M | $65M | · | |
| Operating Income | $-245M | $-143M | $-54M | $-65M | $-5M | |
| Interest Income | · | · | · | · | $27.7K | |
| Other Non-op | · | · | · | $591.7K | $27.7K | |
| Pretax Income | $-230M | $-121M | $-44M | $-64M | · | |
| Income Tax | $611.0K | $282.0K | $94.0K | $36.4K | · | |
| Net Income | $-227M | $-119M | $-36M | $-50M | $-5M | |
| EPS (Basic) | $-3.53 | $-1.89 | $-0.73 | $-1.70 | · | |
| EPS (Diluted) | $-3.53 | $-1.89 | $-0.73 | $-1.70 | · | |
| Shares (Basic) | 64,463,889 | 62,870,237 | 49,122,534 | 29,361,353 | · | |
| Shares (Diluted) | 64,463,889 | 62,870,237 | 49,122,534 | 29,361,353 | 360,000,000 | |
| EBITDA | $-242M | $-142M | · | $-65M | $-5M |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $335M | $180M | $451M | $40M | $8M | |
| Prepaid Expense | $23M | $23M | $2M | $4M | $1M | |
| Current Assets | $422M | $474M | $514M | $77M | $10M | |
| PP&E (Net) | $577.0K | $722.0K | $320.9K | $49.4K | $45.7K | |
| Other Non-current Assets | $596.0K | $0 | · | · | · | |
| Total Assets | $424M | $478M | $527M | $77M | $10M | |
| Accrued Liabilities | · | · | · | · | $4M | |
| Short-term Debt | · | · | · | $0 | $15M | |
| Current Liabilities | $45M | $22M | $10M | $8M | $21M | |
| Capital Leases | $374.0K | $1M | $2M | $129.0K | $0 | |
| Total Liabilities | $120M | $25M | $13M | $8M | $21M | |
| Long-term Debt | $74M | $0 | · | · | · | |
| Total Debt | · | · | · | $0 | · | |
| Common Stock | · | · | · | $0 | $38.5K | |
| Paid-in Capital | $767M | $677M | $610M | $129M | $42M | |
| Retained Earnings | $-463M | $-236M | $-117M | $-81M | $-54M | |
| Treasury Stock | · | · | · | $0 | $6.2K | |
| AOCI | $604.0K | $5M | $2M | $350.9K | $-168.2K | |
| Stockholders' Equity | $304M | $447M | $496M | $49M | $-12M | |
| Liabilities + Equity | $424M | $478M | $527M | $77M | $10M | |
| Shares Outstanding | · | · | · | · | 12,161,331 |
Cashflow 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $3M | $1M | $370.0K | $164.8K | · | |
| Stock-based Comp | $13M | $7M | $7M | $10M | · | |
| Other Non-cash | $16M | $-6M | · | · | · | |
| Operating Cash Flow | $-196M | $-117M | $-43M | $-56M | $-611.1K | |
| CapEx | $35.0K | $520.0K | $284.0K | $16.0K | · | |
| Investing Cash Flow | $203M | $-206M | $-25M | $-32M | · | |
| Debt Issued | $73M | $0 | $0 | · | · | |
| Net Debt Issued | $73M | · | · | · | · | |
| Stock Repurchased | · | $50 | $0 | $0 | · | |
| Net Stock Activity | · | $-50 | · | · | · | |
| Financing Cash Flow | $146M | $51M | $480M | $120M | $-58.1K | |
| Net Change in Cash | $154M | $-271M | $412M | $31M | $-669.1K | |
| Taxes Paid | $799.0K | $147.0K | $42.0K | $4.3K | · | |
| Free Cash Flow | $-196M | $-117M | · | $-56M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -50.4% | -23.7% | · | -115.5% | -3.9% | |
| ROE | -60.5% | -25.2% | · | -268.3% | 94.1% | |
| ROIC | -80.6% | -32.1% | · | -133.1% | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 21.1 | · | 10.0 | 0.2 | |
| Quick Ratio | 7.4 | 8.0 | · | 5.2 | 0.2 | |
| Debt / Equity | · | · | · | 0.0 | · |
Bewertung (TTM) 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-227M | $-119M | $-36M | $-50M | $-5M | |
| P/E | -3.7 | -28.7 | -82.7 | -6.2 | · | |
| Earnings Yield | -26.8% | -3.5% | -1.2% | -16.2% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $50M | $55M | $56M | $61M | $50M | $36M | $40M | $36M | $24M | $13M | $8M | $9M | $7M | $9M | $11M | $10M | |
| SG&A Expense | $11M | $16M | $9M | $11M | $11M | $11M | $9M | $7M | $7M | $7M | $5M | $4M | $6M | $6M | $6M | $5M | |
| Operating Expenses | $62M | $70M | $65M | $71M | $61M | $47M | $50M | $43M | $31M | $20M | $13M | $13M | $13M | $15M | $18M | $16M | |
| Operating Income | $-62M | $-70M | $-65M | $-71M | $-61M | $-47M | $-50M | $-43M | $-31M | $-20M | $-13M | $-13M | $-13M | $-15M | $-18M | $-16M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $657 | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $8.4K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $842.7K | $723.6K | $37.6K | $245.1K | $69.5K | |
| Income Tax | $90.0K | $622.0K | $248.0K | $115.0K | $95.0K | $153.0K | $41.0K | $92.0K | $79.0K | $70.0K | $28.9K | $10.1K | $11.0K | $8.7K | $9.3K | $7.3K | |
| Net Income | $-62M | $-70M | $-62M | $-70M | $-55M | $-40M | $-46M | $-35M | $-24M | $-14M | $-9M | $-10M | $-9M | $-10M | $-12M | $-16M | |
| EPS (Basic) | $-0.84 | $-0.98 | $-0.93 | $-1.10 | $-0.87 | $-0.63 | $-0.72 | $-0.56 | $-0.39 | $-0.22 | $-0.18 | $-0.23 | $-0.23 | $-0.27 | $-0.34 | $-3.17 | |
| EPS (Diluted) | $-0.84 | $-0.98 | $-0.93 | $-1.10 | $-0.87 | $-0.63 | $-0.72 | $-0.56 | $-0.39 | $-0.22 | $-0.18 | $-0.23 | $-0.23 | $-0.27 | $-0.34 | $-3.17 | |
| Shares (Basic) | 73,915,296 | 71,273,650 | -125,422,611 | 63,369,984 | 63,282,728 | 63,233,788 | -125,538,394 | 62,896,782 | 62,874,637 | 62,637,212 | 53,517,655 | 43,718,464 | 39,061,977 | 36,925,639 | 35,201,713 | 5,013,646 | |
| Shares (Diluted) | 73,915,296 | 71,273,650 | -125,422,611 | 63,369,984 | 63,282,728 | 63,233,788 | -125,538,394 | 62,896,782 | 62,874,637 | 62,637,212 | 53,517,655 | 43,718,464 | 39,061,977 | 36,925,639 | 35,201,713 | 5,013,646 | |
| EBITDA | $-62M | $-69M | · | $-71M | $-61M | $-47M | · | $-43M | $-31M | $-20M | $-13M | $-13M | $-13M | $-15M | $-18M | $-3M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $478M | $298M | $335M | $351M | $307M | $272M | $180M | $376M | $343M | $458M | $318M | $502M | $50M | $41M | $93M | $23.3K | |
| Prepaid Expense | $26M | $33M | $23M | $27M | $27M | $23M | $23M | $16M | $15M | $5M | $3M | $4M | $3M | $4M | $5M | $135.9K | |
| Current Assets | $570M | $397M | $422M | $411M | $455M | $506M | $474M | $512M | $537M | $554M | $500M | $506M | $67M | $89M | $98M | $116M | |
| PP&E (Net) | $487.0K | $532.0K | $577.0K | $622.0K | $667.0K | $711.0K | $722.0K | $581.4K | $481.7K | $509.8K | $39.5K | $42.8K | $46.1K | $52.7K | $56.0K | · | |
| Other Non-current Assets | $1M | $1M | $596.0K | $587.0K | $2M | $2M | $0 | · | · | · | · | · | · | · | · | · | |
| Total Assets | $574M | $400M | $424M | $414M | $460M | $511M | $478M | $518M | $545M | $564M | $500M | $507M | $67M | $89M | $98M | $231M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $150.0K | |
| Current Liabilities | $45M | $46M | $45M | $48M | $27M | $24M | $22M | $20M | $12M | $9M | $10M | $7M | $7M | $6M | $4M | $203M | |
| Capital Leases | $772.0K | $865.0K | $374.0K | $486.0K | $836.0K | $1M | $1M | $2M | $2M | $2M | $13.1K | $53.0K | $91.1K | · | · | · | |
| Total Liabilities | $146M | $146M | $120M | $123M | $102M | $99M | $25M | $23M | $15M | $12M | $11M | $8M | $8M | $6M | $4M | $207M | |
| Long-term Debt | $100M | $99M | $74M | $74M | $73M | $73M | $0 | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $150.0K | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $385 | |
| Paid-in Capital | $1.02B | $786M | $767M | $689M | $684M | $681M | $677M | $675M | $672M | $670M | $531M | $590M | $131M | $124M | $122M | $34M | |
| Retained Earnings | $-594M | $-533M | $-463M | $-400M | $-331M | $-276M | $-236M | $-190M | $-155M | $-130M | $-109M | $-100M | $-90M | $-69M | $-59M | $-10M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | |
| AOCI | $630.0K | $322.0K | $604.0K | $278.0K | $520.0K | $2M | $5M | $3M | $3M | $3M | $3M | $35.1K | $340.1K | $245.3K | $133.7K | · | |
| Stockholders' Equity | $428M | $254M | $304M | $289M | $354M | $408M | $447M | $488M | $521M | $543M | $425M | $490M | $42M | $55M | $64M | $24M | |
| Liabilities + Equity | $574M | $400M | $424M | $414M | $460M | $511M | $478M | $518M | $545M | $564M | $500M | $507M | $67M | $89M | $98M | $231M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | 0 | 0 | · |
Cashflow 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $896.0K | $845.0K | $751.0K | $745.0K | $742.0K | $378.0K | $364.0K | $351.0K | $342.0K | $328.0K | · | · | · | · | · | · | |
| Stock-based Comp | $3M | $13M | $4M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $3M | $3M | $2M | $2M | |
| Other Non-cash | · | $-11M | · | · | · | $-864.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-56M | $-66M | $-59M | $-45M | $-55M | $-38M | $-48M | $-25M | $-28M | $-15M | $-9M | $-12M | $-9M | $-9M | $-34M | $-14M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $35.0K | $176.0K | $132.2K | $235 | $212.0K | $0 | $0 | $0 | $0 | $-2 | $16.0K | |
| Investing Cash Flow | $322.0K | $98.0K | $-30M | $88M | $88M | $56M | $-147M | $58M | $-88M | $-29M | $-174M | $13M | $20M | $-42M | $2 | $-16.0K | |
| Debt Issued | $0 | $24M | $0 | $0 | $0 | $73M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Debt Issued | · | $24M | · | · | · | $73M | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $44M | $6M | · | $0 | $0 | $0 | · | $-190 | $-190 | $53M | $0 | $451M | $0 | $0 | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | $0 | $50 | $0 | $0 | $0 | · | · | · | |
| Net Stock Activity | · | $6M | · | · | · | $0 | · | · | · | $53M | · | · | · | · | · | · | |
| Financing Cash Flow | $235M | $31M | $72M | $480.0K | $0 | $73M | $151.0K | $183.1K | $95 | $51M | $0 | $451M | $0 | $0 | $120M | $15M | |
| Net Change in Cash | $179M | $-36M | $-16M | $44M | $35M | $91M | $-195M | $33M | $-116M | $7M | $-184M | $452M | $11M | $-52M | $85M | $795.3K | |
| Taxes Paid | · | · | $733.0K | · | · | · | $143.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-66M | · | · | · | $-38M | · | · | · | $-15M | · | · | $-9M | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -11.9% | -15.3% | · | -14.9% | -11.0% | -7.4% | · | -7.0% | -4.6% | -4.3% | -3.2% | -3.4% | -6.0% | -9.9% | -11.3% | -1.6% | |
| ROE | -15.8% | -21.1% | · | -17.9% | -12.6% | -8.4% | · | -7.8% | -4.8% | -4.7% | -3.9% | -3.7% | -27.1% | -40.1% | -35.4% | -18.4% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.6 | 8.6 | · | 8.5 | 16.6 | 21.1 | · | 25.5 | 43.7 | 62.1 | 48.5 | 71.0 | 9.1 | 14.7 | 25.5 | 0.6 | |
| Quick Ratio | 10.5 | 6.5 | · | 7.3 | 11.2 | 11.3 | · | 18.7 | 27.9 | 51.4 | 30.9 | 70.3 | 6.9 | 6.8 | 24.0 | 0.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -4127.1 |
Bewertung (TTM) 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-256M | $-235M | · | $-200M | $-155M | $-113M | · | $-83M | $-58M | $-42M | $-39M | $-41M | $-47M | $-44M | $-67M | $-55M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $-41M | $-93M | · | |
| P/E | -5.1 | -5.2 | · | -2.3 | -19.3 | -21.7 | · | -37.3 | -43.1 | -58.4 | -62.6 | -47.7 | -5.3 | -1.2 | -0.6 | · | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.8 | 5.3 | · | |
| Earnings Yield | -19.5% | -19.2% | · | -44.1% | -5.2% | -4.6% | · | -2.7% | -2.3% | -1.7% | -1.6% | -2.1% | -18.8% | -82.6% | -172.2% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-227M | $-119M | $-36M | $-50M | $-5M |
| Verwässerte EPS | $-3.53 | $-1.89 | $-0.73 | $-1.70 | — |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | — | — | 0.0 | — |
| Liquiditätsgrad | 9.3 | 21.1 | — | 10.0 | 0.2 |
| Quick Ratio | 7.4 | 8.0 | — | 5.2 | 0.2 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-196M | $-117M | — | $-56M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 197 Einreicher · $1.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 48 (+6 vs. Vorquartal) | 13 (-8 vs. Vorquartal) | 68 (+20 vs. Vorquartal) | 49 (+4 vs. Vorquartal) | +10.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BVF INC/IL | $311.544.999 | 16.001.284 | 25,58% | Aktien |
| Deep Track Capital, LP | $136.271.017 | 6.999.025 | 11,19% | Aktien |
| D. E. Shaw & Co., Inc. | $65.526.421 | 3.365.507 | 5,38% | Aktien |
| Cormorant Asset Management, LP | $62.409.781 | 3.205.433 | 5,12% | Aktien |
| Logos Global Management LP | $52.082.250 | 2.675.000 | 4,28% | Aktien |
| Weiss Asset Management LP | $50.267.899 | 2.581.813 | 4,13% | Aktien |
| CITADEL ADVISORS LLC | $38.412.227 | 1.972.893 | 3,15% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $33.397.845 | 1.715.349 | 2,74% | Aktien |
| MPM BIOIMPACT LLC | $31.287.647 | 1.606.967 | 2,57% | Aktien |
| Nuveen Asset Management, LLC | $30.790.611 | 568.617 | 2,53% | Aktien |
| Vivo Capital, LLC | $27.258.000 | 1.400.000 | 2,24% | Aktien |
| Point72 Asset Management, L.P. | $22.560.512 | 1.158.732 | 1,85% | Aktien |
| Balyasny Asset Management L.P. | $17.770.561 | 912.715 | 1,46% | Aktien |
| GREAT POINT PARTNERS LLC | $16.662.679 | 855.813 | 1,37% | Aktien |
| Candriam S.C.A. | $14.972.924 | 769.766 | 1,23% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $14.617.628 | 750.777 | 1,20% | Aktien |
| Trails Edge Capital Partners, LP | $14.602.500 | 750.000 | 1,20% | Aktien |
| BANK OF AMERICA CORP /DE/ | $13.779.250 | 707.717 | 1,13% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $12.524.428 | 643.268 | 1,03% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $12.386.561 | 636.187 | 1,02% | Aktien |
| Qube Research & Technologies Ltd | $9.661.832 | 496.242 | 0,79% | Aktien |
| JANE STREET GROUP, LLC | $8.824.661 | 453.244 | 0,72% | Aktien |
| ALGERT GLOBAL LLC | $7.534.111 | 386.960 | 0,62% | Aktien |
| Rhenman & Partners Asset Management AB | $7.492.056 | 384.800 | 0,62% | Aktien |
| Trexquant Investment LP | $7.358.609 | 377.946 | 0,60% | Aktien |
| Capricorn Fund Managers Ltd | $7.294.892 | 374.866 | 0,60% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $6.649.725 | 341.537 | 0,55% | Aktien |
| Caption Management, LLC | $6.364.743 | 326.900 | 0,52% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.249.870 | 321.000 | 0,51% | Kaufoption |
| Granahan Investment Management, LLC | $6.111.321 | 313.884 | 0,50% | Aktien |
| Boxer Capital Management, LLC | $5.354.250 | 275.000 | 0,44% | Aktien |
| JANE STREET GROUP, LLC | $5.334.780 | 274.000 | 0,44% | Kaufoption |
| CITADEL ADVISORS LLC | $5.317.257 | 273.100 | 0,44% | Kaufoption |
| Susquehanna Portfolio Strategies, LLC | $4.944.874 | 253.974 | 0,41% | Aktien |
| Holocene Advisors, LP | $4.867.500 | 250.000 | 0,40% | Aktien |
| Burkehill Global Management, LP | $4.867.500 | 250.000 | 0,40% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.823.537 | 247.742 | 0,40% | Aktien |
| Walleye Capital LLC | $4.806.539 | 246.869 | 0,39% | Aktien |
| J. Goldman & Co LP | $4.204.449 | 215.945 | 0,35% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $4.202.580 | 215.849 | 0,35% | Aktien |
| ACUTA CAPITAL PARTNERS, LLC | $4.198.744 | 215.652 | 0,34% | Aktien |
| CITADEL ADVISORS LLC | $4.123.746 | 211.800 | 0,34% | Verkaufsoption |
| Verition Fund Management LLC | $4.032.276 | 207.102 | 0,33% | Aktien |
| HighVista Strategies LLC | $3.659.308 | 187.946 | 0,30% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $3.578.605 | 183.801 | 0,29% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $3.513.323 | 180.448 | 0,29% | Aktien |
| Kalehua Capital Management LLC | $3.421.541 | 175.734 | 0,28% | Aktien |
| Voleon Capital Management LP | $3.386.008 | 173.909 | 0,28% | Aktien |
| Exome Asset Management LLC | $3.241.619 | 166.493 | 0,27% | Aktien |
| Longaeva Partners L.P. | $3.145.515 | 161.557 | 0,26% | Aktien |
| XTX Topco Ltd | $2.968.630 | 152.472 | 0,24% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.943.864 | 151.200 | 0,24% | Verkaufsoption |
| FMR LLC | $2.795.074 | 143.558 | 0,23% | Aktien |
| BlackRock, Inc. | $2.545.819 | 130.756 | 0,21% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.537.467 | 130.327 | 0,21% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.520.080 | 129.434 | 0,21% | Aktien |
| Caption Management, LLC | $2.509.683 | 128.900 | 0,21% | Verkaufsoption |
| TD Asset Management Inc | $2.497.495 | 128.274 | 0,21% | Aktien |
| Engineers Gate Manager LP | $2.172.657 | 111.590 | 0,18% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.142.000 | 110.000 | 0,18% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.133.523 | 109.580 | 0,18% | Aktien |
| Quadrature Capital Ltd | $2.126.202 | 109.204 | 0,17% | Aktien |
| Polymer Capital Management (HK) LTD | $1.956.015 | 100.463 | 0,16% | Aktien |
| Centiva Capital, LP | $1.947.000 | 100.000 | 0,16% | Kaufoption |
| HEIGHTS CAPITAL MANAGEMENT, INC | $1.947.000 | 100.000 | 0,16% | Aktien |
| J. Goldman & Co LP | $1.947.000 | 100.000 | 0,16% | Kaufoption |
| Ghisallo Capital Management LLC | $1.947.000 | 100.000 | 0,16% | Aktien |
| SummitTX Capital, L.P. | $1.934.753 | 99.371 | 0,16% | Aktien |
| Jain Global LLC | $1.929.983 | 99.126 | 0,16% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.735.806 | 131.700 | 0,14% | Aktien |
| STATE STREET CORP | $1.697.122 | 87.166 | 0,14% | Aktien |
| Swiss National Bank | $1.695.837 | 87.100 | 0,14% | Aktien |
| Squarepoint Ops LLC | $1.657.812 | 85.147 | 0,14% | Aktien |
| Monashee Investment Management LLC | $1.460.250 | 75.000 | 0,12% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.454.836 | 74.760 | 0,12% | Aktien |
| Mariner, LLC | $1.418.907 | 72.875 | 0,12% | Aktien |
| Lion Point Capital, LP | $1.314.225 | 67.500 | 0,11% | Aktien |
| CAPITAL FUND MANAGEMENT S.A. | $1.273.221 | 65.394 | 0,10% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $1.143.668 | 58.740 | 0,09% | Aktien |
| Headlands Technologies LLC | $1.111.484 | 57.087 | 0,09% | Aktien |
| HAP Trading, LLC | $1.015.000 | 40.000 | 0,08% | Verkaufsoption |
| Stonepine Capital Management, LLC | $973.500 | 50.000 | 0,08% | Aktien |
| ExodusPoint Capital Management, LP | $908.198 | 46.646 | 0,07% | Aktien |
| JANE STREET GROUP, LLC | $819.687 | 42.100 | 0,07% | Verkaufsoption |
| VANGUARD ASSET MANAGEMENT, Ltd | $704.717 | 36.195 | 0,06% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $627.985 | 32.254 | 0,05% | Aktien |
| Campbell & CO Investment Adviser LLC | $577.831 | 29.678 | 0,05% | Aktien |
| Aquatic Capital Management LLC | $547.769 | 28.134 | 0,04% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $546.077 | 29.296 | 0,04% | Aktien |
| Quantbot Technologies LP | $541.402 | 27.807 | 0,04% | Aktien |
| Schonfeld Strategic Advisors LLC | $536.884 | 27.575 | 0,04% | Aktien |
| ADAR1 Capital Management, LLC | $525.690 | 27.000 | 0,04% | Aktien |
| FOX RUN MANAGEMENT, L.L.C. | $517.707 | 26.590 | 0,04% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $506.162 | 25.997 | 0,04% | Aktien |
| IEQ CAPITAL, LLC | $483.927 | 24.855 | 0,04% | Aktien |
| Optimize Financial Inc | $455.170 | 24.419 | 0,04% | Aktien |
| IMC-Chicago, LLC | $448.745 | 23.048 | 0,04% | Aktien |
| AXA Investment Managers S.A. | $435.613 | 60.755 | 0,04% | Aktien |
| Graham Capital Management, L.P. | $419.481 | 21.545 | 0,03% | Aktien |
| Entropy Technologies, LP | $386.032 | 19.827 | 0,03% | Aktien |
Unternehmensinsider 10 Insider · 3 Führungskräfte · 6 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Da Silva Jorge Santos | Chief Executive Officer | 10. Juli 2026 S | 2.774.893 | 0 | 7 | $-8.730.001 |
| Matthias Bodenstedt | Chief Financial Officer | 22. Juni 2026 S | 1.115.435 | 1 | 7 | $-3.099.694 |
| Kristian Reich | Chief Scientific Officer | 27. Juli 2026 S | 2.711.198 | 0 | 10 | $-8.135.616 |
| Andrew John Phillips | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
| Ramnik Xavier | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
| Loy Spike | Direktor | 17. Juni 2026 A | — | 0 | 0 | $0 |
| Catherine Moukheibir | Direktor | 17. Juni 2026 A | 0 | 0 | 0 | $0 |
| Simon Sturge | Direktor | 5. Juni 2025 A | 171.980 | 0 | 0 | $0 |
| Chen Bihua | 10%-Eigentümer | 30. Juni 2023 P | 4.927.100 | 0 | 0 | $0 |
| Helix Holdings LLC | — | 5. April 2022 C | 3.215.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Loy Spike ×3 Einreichungen | 29. Juni 2026 | 19,70% | Änderung | — | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, SPIKE LOY ×4 Einreichungen | 8. Oktober 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 8 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,88% | 73.934 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,82% | 18.661 NS | 30. April 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 82.021 SH | 8. August 2026 | Täglich |
| NUSC · Nushares ETF Trust | 0,04% | 33.673 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 130.327 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 14.568 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 3.105 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 30.712 NS | 31. Mai 2026 | N-PORT |